A Review Article on Smart Phyto-nanoemulgel Systems for Modulation of Inflammatory Mediators in Rheumatoid Arthritis

Abstract:

This review article offers a thorough examination of nanoemulgel-based drug delivery methods for rheumatoid arthritis (RA) treatment. The study delves into the fusion of nanotechnology with gel-based systems, underscoring their superior drug-delivery capabilities, controlled release, and targeted therapeutic potential for managing rheumatoid arthritis. It also provides a detailed exploration of the use of herbal plants in the treatment of arthritis, focusing on traditional remedies, active components, mechanisms of action, and pharmacological strategies to enhance their administration. These approaches are designed to improve bioavailability, support targeted distribution, and allow for controlled release of herbal constituents. Safety considerations, including potential drug interactions and the risk of allergic responses, are also addressed. Rheumatoid arthritis is a debilitating condition characterized by inflammation of the synovial membrane, leading to cartilage and bone degradation. Numerous medications, including anti-inflammatory drugs and disease-modifying antirheumatic therapies, can assist in its management; also, phytotherapy presents a promising and advantageous approach for treating rheumatoid arthritis, due to its capacity to target a range of inflammatory substances, such as nitric oxide (NO), cytokines, chemokines, and adhesion molecules, especially given the significant side effects associated with conventional treatments. Additionally, nanomedicine offers a valuable formulation approach to address challenges associated with phytoconstituents, including poor bioavailability, high first-pass metabolism, and reduced stability. This review provides an extensive overview of numerous phytoconstituents with significant potential in the management of RA, their limitations, innovative drug formulations reported, and the relevant regulatory considerations.